Heterotandem bicyclic peptide complexes
US11453703B2 · kind B2 · utility
5Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2019 |
| Grant date | Sep 27, 2022 |
| Priority date | — |
| Expiry date | Apr 2, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K17/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to heterotandem bicyclic peptide complexes which comprise a first peptide ligand, which binds to a component present on an immune cell, conjugated via a linker to a second peptide ligand, which binds to a component present on a cancer cell. The invention also relates to the use of said heterotandem bicyclic peptide complexes in preventing, suppressing or treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.